Annual ROE
-29.11%
-78.13%-159.38%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual return on equity is -29.11%, with the most recent change of -78.13% (-159.38%) on December 31, 2023.
- During the last 3 years, ELVN annual ROE has fallen by -122.52% (-131.16%).
- ELVN annual ROE is now -131.16% below its all-time high of 93.41%, reached on December 1, 2020.
Performance
ELVN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-29.46%
-0.15%-0.51%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly return on equity is -29.46%, with the most recent change of -0.15% (-0.51%) on September 30, 2024.
- Over the past year, ELVN quarterly ROE has dropped by -0.63% (-2.19%).
- ELVN quarterly ROE is now -144.79% below its all-time high of 65.78%, reached on September 30, 2022.
Performance
ELVN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ELVN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -159.4% | -2.2% |
| 3 y3 years | -131.2% | +67.1% |
| 5 y5 years | -131.2% | +67.1% |
ELVN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -150.5% | at low | -144.8% | +67.1% |
| 5 y | 5-year | -131.2% | at low | -144.8% | +67.1% |
| alltime | all time | -131.2% | at low | -144.8% | +67.1% |
Enliven Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -29.46%(+0.5%) |
| Jun 2024 | - | -29.31%(+1.7%) |
| Mar 2024 | - | -28.83%(+8.5%) |
| Dec 2023 | -29.11%(-159.4%) | -26.56%(-18.8%) |
| Sep 2023 | - | -32.71%(-32.5%) |
| Jun 2023 | - | -48.46%(-45.9%) |
| Mar 2023 | - | -89.53%(-272.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | 49.02%(-15.0%) | 51.98%(-21.0%) |
| Sep 2022 | - | 65.78%(+8.7%) |
| Jun 2022 | - | 60.51%(+52.1%) |
| Mar 2022 | - | 39.78%(+103.3%) |
| Dec 2021 | 57.69%(-38.2%) | - |
| Dec 2021 | - | 19.57% |
| Dec 2020 | 93.41% | - |
FAQ
- What is Enliven Therapeutics annual return on equity?
- What is the all time high annual ROE for Enliven Therapeutics?
- What is Enliven Therapeutics annual ROE year-on-year change?
- What is Enliven Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly ROE year-on-year change?
What is Enliven Therapeutics annual return on equity?
The current annual ROE of ELVN is -29.11%
What is the all time high annual ROE for Enliven Therapeutics?
Enliven Therapeutics all-time high annual return on equity is 93.41%
What is Enliven Therapeutics annual ROE year-on-year change?
Over the past year, ELVN annual return on equity has changed by -78.13% (-159.38%)
What is Enliven Therapeutics quarterly return on equity?
The current quarterly ROE of ELVN is -29.46%
What is the all time high quarterly ROE for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly return on equity is 65.78%
What is Enliven Therapeutics quarterly ROE year-on-year change?
Over the past year, ELVN quarterly return on equity has changed by -0.63% (-2.19%)